Skip to main content

In this Issue

  • Pet meds barking up retail’s tree

    A typical retail pharmacy is equipped to handle most of the prescription needs of its customers, whether they have a skin rash, chronic illness or the need for a vaccination against the flu or shingles.


    With the plethora of health needs facing humans these days, it’s easy to forget that Fluffy and Fido have a few health needs of their own — needs that are driving sales of prescription drugs for pets and opening opportunities for pharmacy retailers.


  • Flu season wreaks havoc on suppliers

    It was the cough, cold and flu season that wasn’t. The percentage of patient visits on account of influenza-like illnesses never eclipsed the 2.4% baseline that typically marks the beginning and end of a flu season. According to the Centers for Disease Control and Prevention, the closest the 2011-2012 flu season came to materializing was the week ended March 17, when 2.384% of all office visits were attributed to ILI symptoms nationwide. 


  • FDA debates expansion of switch paradigm

    Get set for another decade of explosive growth throughout the over-the-counter category with the familiar switch as a catalyst. 


    The Food and Drug Administration public meeting that took place last month addressed a proposal to expand the switch paradigm by utilizing the latest in communications and diagnostics technology and/or incorporating the most accessible healthcare professional — the retail pharmacist — into the self-care decision protocol. 


  • Customizing the in-store experience

    Move over dump bins, endcap displays and newspaper circulars and make room for the new high-tech kid on the retail block — digitization.
    Smartphones and the concept of digital coupons may not be so new, but what is relatively new to the mass market and becoming increasingly pervasive throughout the industry is the use of mobile technologies and social networking platforms — by both retailers and manufacturers — to customize offers for today’s shopper.

  • Readers’ PBM perspectives

    A guest column in the March 12 issue of DSN, “Let me tell you what PBMs do,” by Republican Utah State Rep. Evan Vickers, really set off a firestorm of debate on DrugStoreNews.com and on DSN’s social media sites. Check out this snippet from two online users with VERY different perspectives on all of this. For Rep. Vickers’ complete column and to add your own views to the debate, click here.


  • Got consumer insights?

    Want to know what hundreds of consumers think about your brand and how they shop your stores? Introducing DSN/C2B Mobile Insights powered by engage.me.


  • Dougherty’s raises bar with unique offering

    DALLAS — Eighty-two-year-old independent Dougherty’s Pharmacy is operating a pharmacy inside the Forest Park Medical Center, which it opened in August. The pharmacy’s decor includes Italian tile wall treatments, a wavy wall behind the cash wrap and works by local Dallas artists.

  • Increase in Rx costs surpasses inflation rate

    Increases in the prices of prescription drugs have far outpaced the rate of general inflation over the years, as increases in the prices of branded and specialty drugs have offset decreases in the prices of generics, according to a new report by AARP’s research arm.


    The study, conducted by AARP’s Public Policy Institute, found that the cumulative change in drug prices from 2005 to 2009 was almost double the rate of inflation. As a result, the average annual cost of drug therapy continued to rise.


X
This ad will auto-close in 10 seconds